- Home
- GHI vs DRTS Comparison
GHI vs DRTS Comparison
Compare GHI & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHI
- DRTS
- Stock Information
- Founded
- GHI 1998
- DRTS 2015
- Country
- GHI United States
- DRTS Israel
- Employees
- GHI N/A
- DRTS N/A
- Industry
- GHI Finance: Consumer Services
- DRTS Medical/Dental Instruments
- Sector
- GHI Finance
- DRTS Health Care
- Exchange
- GHI Nasdaq
- DRTS Nasdaq
- Market Cap
- GHI 254.1M
- DRTS 300.2M
- IPO Year
- GHI N/A
- DRTS N/A
- Fundamental
- Price
- GHI $9.99
- DRTS $3.91
- Analyst Decision
- GHI Strong Buy
- DRTS Strong Buy
- Analyst Count
- GHI 4
- DRTS 1
- Target Price
- GHI $14.88
- DRTS $9.00
- AVG Volume (30 Days)
- GHI 60.0K
- DRTS 60.3K
- Earning Date
- GHI 11-05-2025
- DRTS 11-18-2025
- Dividend Yield
- GHI 14.83%
- DRTS N/A
- EPS Growth
- GHI N/A
- DRTS N/A
- EPS
- GHI N/A
- DRTS N/A
- Revenue
- GHI $27,326,828.00
- DRTS N/A
- Revenue This Year
- GHI $223.15
- DRTS N/A
- Revenue Next Year
- GHI $5.11
- DRTS N/A
- P/E Ratio
- GHI N/A
- DRTS N/A
- Revenue Growth
- GHI N/A
- DRTS N/A
- 52 Week Low
- GHI $9.97
- DRTS $2.12
- 52 Week High
- GHI $13.74
- DRTS $4.69
- Technical
- Relative Strength Index (RSI)
- GHI 34.97
- DRTS 48.74
- Support Level
- GHI $10.10
- DRTS $3.75
- Resistance Level
- GHI $10.44
- DRTS $4.45
- Average True Range (ATR)
- GHI 0.22
- DRTS 0.27
- MACD
- GHI -0.03
- DRTS -0.08
- Stochastic Oscillator
- GHI 1.23
- DRTS 14.89
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.